What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to…
Continue Reading
What You Should Know:
– Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their…
Continue Reading
What You Should Know:
– Verantos, the leader in high-quality real-world evidence (RWE) forms a strategic partnership with CuriMeta to expand Verantos’ Research Network with de-identified data from 7 million patients,
– The collaboration will enhance…
Continue Reading
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned…
Continue Reading
What You Should Know:
– The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC’s oncology care…
Continue Reading
public
What You Should Know:
– Truveta, a consortium of 30 health systems united in “Saving Lives with Data,” has secured a significant partnership with the U.S. Centers for Disease Control and Prevention (CDC).
– This collaboration…
Continue Reading
James Coutcher, Sr.Director and Global Head of Emerging Methods and Solutions for IQVIA
In today’s complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are…
Continue Reading
What You Should Know:
– ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
– This strategic move will significantly enhance and…
Continue Reading
What You Should Know:
– Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of…
Continue Reading
What You Should Know:
– Veradigm Inc. (NASDAQ: MDRX), a provider of healthcare data and technology solutions, announced it has made a $30M strategic investment in Holmusk, a global behavioral health real-world evidence company. The…
Continue Reading
